Reference number : 236-2012-2013-Q1-00252, amendment number : , agreement type : G, recipient legal name : LI, Shyh-Dar, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 1L7, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 160000.0, agreement start date : 2012-10-01, agreement end date : 2013-09-30, description english : Benchmark Cellax, a proprietary nanoparticle formulation for docetaxel, against Taxotere to treat metastatic castration resistant prostate cancer, description french : Benchmark Cellax, a proprietary nanoparticle formulation for docetaxel, against Taxotere to treat metastatic castration resistant prostate cancer, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2012-13 to 2013-14), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2012-13 à 2013-14), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada